BJDX

Bluejay Diagnostics, Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website bluejaydx.com
Employees(FY) 16
ISIN US0956335097

Performance

-16.52%

+18.52%

+2419.69%

+30.86%

-60.66%

YTD

-83.78%

Profile

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Advanced Technical Analysis

Technical Analysis of BJDX 2024-12-20

The stock's Moving Average Score of 63 indicates a bullish trend, while the Oscillators Score of 43 suggests a neutral sentiment, and the overall Technical Score of 53 reinforces a mixed outlook. This combination implies a cautiously optimistic sentiment, with the potential for upward movement tempered by some indecision in the market.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of BJDX

Stock Rank

Recent News & Updates

2024-11-13 04:10
Bluejay Diagnostics Announces Reverse Stock Split(Globenewswire)
2024-06-27 23:32
Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering(Globenewswire)
2024-06-26 20:58
Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering(Globenewswire)
2024-06-26 19:34
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday(Investorplace)
2024-06-25 20:00
SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients(Globenewswire)
2024-06-16 20:00
Bluejay Diagnostics Announces Reverse Stock Split(Globenewswire)
2024-06-16 19:40
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday(Investorplace)
2024-03-28 11:53
BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q4 2023(Investorplace)
2024-01-02 04:58
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering(Globenewswire)
2023-12-27 19:00
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering(Globenewswire)
2023-12-26 20:00
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)(Globenewswire)
2023-11-09 03:05
Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results(Globenewswire)
2023-08-27 19:59
BJDX: FDA Meeting Confirms Pathway(Yahoo Finance)
2023-08-24 20:00
Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules(Yahoo Finance)
2023-08-15 19:00
Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results(Yahoo Finance)
2023-08-10 04:05
Bluejay Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement(Yahoo Finance)
2023-07-23 20:30
Will Bluejay Diagnostics (NASDAQ:BJDX) Spend Its Cash Wisely?(Yahoo Finance)
2023-07-20 19:00
Bluejay Diagnostics Announces Reverse Stock Split(Yahoo Finance)
2023-05-30 18:36
BJDX: Orchestrating a New Testing Standard(Yahoo Finance)
2023-05-18 19:00
Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy(Yahoo Finance)
2023-05-09 19:30
Bluejay Diagnostics Reports First Quarter 2023 Financial Results(Yahoo Finance)
2023-03-20 04:15
Bluejay Diagnostics Reports 2022 Financial Results(Yahoo Finance)
2023-02-15 19:00
Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America(Yahoo Finance)
2022-11-12 19:01
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) drops to US$14m and insiders who purchased earlier this year lose another US$65k(Yahoo Finance)
2022-11-08 19:00
Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results(Yahoo Finance)
2022-08-30 04:05
Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference(Yahoo Finance)
2022-08-23 18:09
Here's Why We're Watching Bluejay Diagnostics' (NASDAQ:BJDX) Cash Burn Situation(Yahoo Finance)
2022-08-15 19:30
Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure(Yahoo Finance)
2022-07-26 19:30
Positive Clinical Results for Bluejays Symphony IL-6 Test Presented at AACC 2022(Yahoo Finance)
2022-07-26 04:30
Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results(Yahoo Finance)

Page 1 of 2

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.